drugset
drugset / Trial / NCT03673527

Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin

NCT03673527 ↗

Phase 1 Completed 24 enrolled LEO Pharma
NaSingle-groupOpen-labelOther

Summary

This is a phase I trial to evaluate tacrolimus blood levels after topical application of tacrolimus twice daily on healthy skin.

Timeline

Start
2018-11-22
Primary completion
2019-02-04
Completion
2019-02-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule — Topical

Indications

No indication recorded.